ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028

ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028

The Asia Pacific dermatological therapeutics market is set to record growth at a CAGR of 7.96% during the forecast period, 2019-2028. The rising awareness and the ever-growing pool of patients are the beneficial factors evaluated to be contributing to the market growth. Japan, India, China, South Korea, Vietnam, Thailand, Australia & New Zealand, Indonesia, and the rest of Asia Pacific are assessed for the Asia Pacific dermatological therapeutics market growth analysis. China is set to witness a considerable surge in its aging population.

ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028

Asia Pacific Dermatological Therapeutics Market by Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, Other Drug Classes) by Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Acne Vulgaris, Other Applications) and by Geography.

Request free sample

The Asia Pacific dermatological therapeutics market is set to record growth at a CAGR of 7.96% during the forecast period, 2019-2028. The rising awareness and the ever-growing pool of patients are the beneficial factors evaluated to be contributing to the market growth.
Asia Pacific Dermatological Therapeutics Market

To know more about this report, request a free sample copy

Japan, India, China, South Korea, Vietnam, Thailand, Australia & New Zealand, Indonesia, and the rest of Asia Pacific are assessed for the Asia Pacific dermatological therapeutics market growth analysis. China is set to witness a considerable surge in its aging population. The geriatric population is more susceptible to dermatological diseases. Therefore, this becomes a contributing factor to market growth. There has also been a rise in the cases of dermatological diseases. Such factors have resulted in an increased number of Years Lived with Disability (YLDS) due to skin disease in the last 27 years. The growing number of skin diseases majorly entails dermatitis and scabies. With increasing procedures and physicians in the dermatology sector, market growth is set to propel in the coming years. Moreover, technological advancements, awareness, and increasing lifestyle changes, are assessed to be beneficial for the market growth prospects of the country.

Thailand is often ravaged by floods. The floods bring with it infectious dermatoses, a superficial fungal infection in particular. Eczema was considered to be the most prevalent dermatoses. It also accounted for 34.5% of the total skin problems in the country. Such factors are set to influence the growth of the market in Thailand.

Merck KGaA is a manufacturer and marketer of pharmaceutical products, specialty chemicals, and life science tools. The company has strong research and development capabilities. It prioritizes the development of new products and services for enhancing the quality of life of patients. The company’s business presence extends to Asia Pacific, North America, Europe, the Middle East & Africa, and Latin America. The company has its headquarters in Darmstadt, Germany.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • RISING LOAD OF DERMATOLOGY DISEASES
      • RISE IN AWARENESS LEVELS OF DISEASE PROGRESSION AND ORIGIN
    •    KEY RESTRAINTS
      • SEVERE SIDE EFFECTS OF CERTAIN CLASSES OF THERAPEUTIC DRUGS
  1. KEY ANALYTICS
    • KEY INVESTMENT INSIGHTS
    •    PORTER’S FIVE FORCE ANALYSIS
      • BUYER POWER
      • SUPPLIER POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY DRUG CLASS
    • ANTI-INFECTIVES
    • CORTICOSTEROIDS
    • ANTI-ACNE
    • CALCINEURIN INHIBITORS
    • RETINOIDS
    • OTHER DRUG CLASSES
  3. MARKET BY APPLICATION
    • ALOPECIA
    • HERPES
    • PSORIASIS
    • ROSACEA
    • ATOPIC DERMATITIS
    • ACNE VULGARIS
    • OTHER APPLICATIONS
  4. GEOGRAPHICAL ANALYSIS
    •    ASIA PACIFIC
      • CHINA
      • JAPAN
      • INDIA
      • SOUTH KOREA
      • INDONESIA
      • THAILAND
      • VIETNAM
      • AUSTRALIA & NEW ZEALAND
      • REST OF ASIA PACIFIC
  1. COMPANY PROFILES
    • ABBVIE INC
    • ALLERGAN INC
    • ALMIRAL
    • AMGEN INC
    • BAUSCH HEALTH COMPANIES INC
    • GALDERMA
    • GLAXOSMITHKLINE PLC
    • JOHNSON & JOHNSON
    • NOVARTIS AG
    • PFIZER INC
    • AGI DERMATICS
    • LEO PHARMA A/S
    • MERCK KGAA

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – DERMATOLOGICAL THERAPEUTICS

TABLE 2: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)

TABLE 3: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028 (IN $ BILLION)

TABLE 4: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)

TABLE 5: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY, APPLICATION, FORECAST YEARS, 2019-2028 (IN $ BILLION)

TABLE 6: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)

TABLE 7: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)

LIST OF FIGURES

FIGURE 1: KEY INVESTMENT INSIGHTS

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, GROWTH POTENTIAL, BY DRUG CLASS, IN 2019

FIGURE 6: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $ BILLION)

FIGURE 7: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $ BILLION)

FIGURE 8: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)

FIGURE 9: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $ BILLION)

FIGURE 10: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)

FIGURE 11: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $ BILLION)

FIGURE 12: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019

FIGURE 13: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)

FIGURE 14: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)

FIGURE 15: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $ BILLION)

FIGURE 16: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $ BILLION)

FIGURE 17: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028 (IN $ BILLION)

FIGURE 18: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $ BILLION)

FIGURE 19: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ BILLION)

FIGURE 20: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 21: CHINA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 22: JAPAN DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 23: INDIA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 24: SOUTH KOREA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 25: INDONESIA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 26: THAILAND DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 27: VIETNAM DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 28: AUSTRALIA & NEW ZEALAND DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 29: REST OF ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    ASIA PACIFIC
      • CHINA
      • JAPAN
      • INDIA
      • SOUTH KOREA
      • INDONESIA
      • THAILAND
      • VIETNAM
      • AUSTRALIA & NEW ZEALAND
      • REST OF ASIA PACIFIC
  1. MARKET BY DRUG CLASS
    • ANTI-INFECTIVES
    • CORTICOSTEROIDS
    • ANTI-ACNE
    • CALCINEURIN INHIBITORS
    • RETINOIDS
    • OTHER DRUG CLASSES
  2. MARKET BY APPLICATION
    • ALOPECIA
    • HERPES
    • PSORIASIS
    • ROSACEA
    • ATOPIC DERMATITIS
    • ACNE VULGARIS
    • OTHER APPLICATIONS

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now